- Novira Plaza
- Marijas iela 2a, Centra rajons
- LV-1050 Rīga
- Latvia
- riga@eib.org
Contact us
More press releases
Netherlands: Xeltis secures nearly €50m from the EIB and existing shareholders to advance aXess, its vascular access conduit to the market
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting blood vessels, today announces that it has secured nearly €50m of new financing, consisting of up to €37.5m from the EIB, supported under the European Commission’s InvestEU programme, and €10m from existing investors, including EQT, investing from its LSP Health Economics Fund 2, and Invest-NL. The proceeds raised will be used to advance aXess into commercialization, including upscaling production and hiring, and supporting the continued development of its broader pipeline. The EIB venture debt package consists of €10 million up front with optionality to further increase by an additional €27.5 million
Italy: €150 million agreement between EIB and Angelini Ventures to finance European startups
The European Investment Bank (EIB) and Angelini Ventures – Angelini Industries’ corporate venture capital fund – have signed an agreement to provide a total of €150 million in financing for European biotechnology and digital health startups. This is the first agreement the EIB has signed with a corporate venture capital in healthcare sector, and states that Angelini Ventures and the EIB will each invest €75 million over the next six years.
EIB Global and EU, under the Global Gateway Initiative, support wind farm expansion in Cabo Verde
Today, new wind turbines and a battery system were inaugurated in Cabo Verde, thanks to additional financing of more than €39 million from the European Investment Bank (EIB), through its development arm EIB Global, and backed by EU guarantees. The African Development Bank has co-financed the expansion.